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The data described here supports the research article “Unraveling
HIV Protease Flaps Dynamics by Constant pH Molecular Dynamics
Simulations” (Soares et al., 2016) [1]. The data involves both
standard Molecular Dynamics (MD) and Constant pH Molecular
Dynamics (CpHMD) to elucidate the effect of protonation states of
catalytic dyad on the HIV-PR conformation. The data obtained
from MD simulation demonstrate that the protonation state of the
two aspartic acids (Asp25/Asp250) has a strong inﬂuence on the
dynamics of the HIV-PR. Regarding the CpHMD simulation, we
performed pka calculations for HIV-PR and the data indicate that
only one catalytic aspartate should be protonated.
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Biophysics, Biochemistry
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rotonated (green line), mGraph, ﬁgure and table
ow data was
acquiredStandard and constant pH molecular dynamics simulation of HIV-PR was
performed using GROMACS 4.4 [2], GROMOS96 force ﬁeld [3], Amber12 [4]
and AMBERff99SB force ﬁeld [5].ata format Analyzed
xperimental
factorsThe systems were minimization until reaching a gradient of 2.39 kcal mol1
Ǻ1 then equilibrated for 4 ns.
xperimental
featuresNPT ensemble at 300 Kata source
locationInstitute of Biophysics Carlos Chagas Filho (IBCCF), Federal University of Rio
de Janeiro (UFRJ), Rio de Janeiro, Brazilata accessibility Data is within this articleD
Value of the data
 The present data demonstrate the importance of the protonation states in molecular simulations
and provide new insights regarding HIV-PR ﬂap conformation.
 These data ﬁndings might be useful to the selection of the protonation state in HIV-PR.
 The results highlight the importance of the constant pH molecular dynamics CpHMD technique.
 The CpHMD method used in this work provides new insights into the pH dependent activity of the
HIV-PR.1. Data
The data presented here comprise results obtained from MD and CpHMD to investigate the
functional role of protonation states on HIV-PR. The analyses that were carried out employed mainly
three systems: free HIV-PR, HIV-PR complexed with a natural substrate (p1p6 peptide) and HIV-PR
complexed with an inhibitor compound (Nelﬁnavir). We have measured the root mean square
deviation proﬁle in different protonation states using standard MD simulation (Fig. 1), root mean
square ﬂuctuation in different pH values using CpHMD (Fig. 2, Table 1), protonation ratio of all
ionizable residues (Fig. 3) and conformational cluster analysis (Fig. 4). Table 2 elucidates an unusually
low predicted pKa for Glu35, through a hydrogen bond prevalence analysis.n the distribution of RMSD distance of all the pair of conformations of the trajectory of the
onoprotonated (black line) and diprotonated (red line) HIV-PR.
Fig. 2. (A) HIV-PR protease backbone ﬂuctuations at pH 5 (black line), 6 (red line) and 7 (green line). (A) Apo HIV-PR. (B) p1p6-
bound HIV-PR. (C) nelﬁnavir-bound HIV. The chain A residues are numbered from 1-99 and 1’99’ from chain B.
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Table 1
Calculated pKa values for residues from apo, p1p6 and bound-nelﬁnavir HIV-PR at pH 7 over 40 ns and 80 ns.
Residue Codon HIV-PRapo HIV-PRp1/p6 HIV-PRNel
40 ns 80 ns 40 ns 80 ns 40 ns 80 ns
Chain
A
Chain
B
Chain
A
Chain
B
Chain
A
Chain
B
Chain
A
Chain
B
Chain
A
Chain
B
Chain
A
Chain
B
GLU 21/210 4.4 4.0 4.4 4.1 4.5 3.9 4.7 3.7 4.3 4.2 4.5 4.3
ASP 25/250 7.2 5.7 6.6 5.4 5.7 6.9 5.4 6.5 9.3 4.3 9.6 4.0
ASP 29/290 2.8 2.8 2.8 2.7 2.7 2.5 2.5 2.9 3.6 2.7 3.3 2.6
ASP 30/300 4.7 4.6 4.7 4.5 4.1 3.3 3.8 3.8 5.1 4.5 4.9 4.3
GLU 34/340 4.2 4.1 4.2 4.0 4.5 3.7 4.4 3.4 4.4 3.8 4.5 3.8
GLU 35/350 2.8 2.3 2.8 3.0 3.4 2.5 3.2 2.4 3.2 2.8 3.0 2.7
ASP 60/600 2.3 1.6 2.3 1.8 1.5 2.8 2.9 2.8 0.9 2.0 2.0 1.7
GLU 65/650 3.8 3.8 3.7 3.8 3.2 2.9 3.2 3.0 3.6 3.8 3.6 3.7
HIS 69/690 7.0 7.2 7.1 7.2 6.9 6.9 7.0 6.9 7.1 7.0 7.1 7.1
- (Dash) denotes that the pka value was not possible to be calculated, because there was no enough change in the protonation of
residue.
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2.1. Systems Setup
The atomic coordinate entries available in the PDB under accession codes 1OHR [6] and 1KJF [7]
were used as initial condition of the NFV and p1/p6 bound-HIV-PR, respectively. The crystal structure
2HB4 was used as apo form of HIV-PR [8]. Before starting the simulation on the 1KJF structure, we
performed the mutation N25D [1].2.2. MD simulations
The nelﬁnavir-bound HIV-PR was simulated under three different protonation states in the cata-
lytic residues: deprotonated (both residues are not protonated), monoprotonated (only the Asp25’ is
protonated) and deprotonated (both residues are protonated). We performed MD simulations with
the program package GROMACS v. 4.4, using the GROMOS96 (43A1) force ﬁeld and the SPC water
model [9]. The solvation procedure was performed with a layer of at least 15 Å around the complex
(approximately 11,350 water molecules). Due to their net positive charge, an appropriate number of
chloride counter-ions were added to neutralize the system. The topology for nelﬁnavir was taken
from a previous reference [10]. For Coulomb interactions, the reaction ﬁeld correction term [11] was
employed, with Cutoff 1.4 Å and a dielectric constant set to 54 [12]. All systems were run in periodic
boundary conditions and the NPT ensemble. The temperature was maintained at 300 K and pressure
at 1 atm using the Berendsen weak coupling approach [13]. LINCS and SETTLE were applied to con-
strain solute and solvent bonds respectively. Each initial set up was optimized using three different
steps. First, an energy minimization using the steepest-descent algorithm was made restraining the
protein and ligand heavy atoms to their original positions with a harmonic potential of
10 kcal mol1 Ǻ2. Then, another minimization using steepest-descent with no restraints was per-
formed. Finally, an energy minimization procedure with all restraints already removed was con-
ducted, using the conjugate gradient method until reaching a gradient of 2.39 kcal mol1 Ǻ1. Fol-
lowing the minimization, two stages of equilibration were performed: a 500 ps of MD with protein
non-hydrogen atoms positions restrained by harmonic potential of 2 kcal mol1 Ǻ2, in a NVT
ensemble and other of 2 ns MD simulation with no position restraints, in a NPT ensemble. Finally,
60 ns of MD were conducted for further analysis.
Fig. 3. The protonation fraction of all Glu, Asp and His from apo (panel A), p1p6-bound (panel B) and nelﬁnavir-bound HIV-PR
(panel C) at pH values of 5 (black bars), 6 (red bars) and 7 (green bars). The charts on the left represent the A chain, whilst the
ones on the right represent the B chain.
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The HIV-PR was simulated in its apo form, and bound to p1p6 and nelﬁnavir at pH 5.0 pH 6.0 and
pH 7.0 for 40 ns and 80 ns. The CpHMD simulations were performed with the program package
Amber12 and the AMBER ff99SB force ﬁeld [5]. The parameters for nelﬁnavir were obtained using the
antechamber module and the GAFF force ﬁeld [14]. All systems were run using implicit solvation
Fig. 4. Correlation between the conformational and protonation states for apo (panel A), p1p6-bound (panel B) and nelﬁnavir-
bound HIV-PR (panel C) at pH 7. The y axis represents the RMSD cluster number on the respective time frame (x axis). The blue,
red and yellow bars represent deprotonated, protonation of Asp25 and protonation of Asp25', respectively. The Dashed lines
point to the centroids of the three most prevalent clusters found throughout the simulation time of the apo system (clusters 1,
2 and 3). The clusters centroids of the remaining systems ("p1p6" and "nel") were not represented.
Table 2
Prevalence (%) of hydrogen bond interactions between Glu 35 and Arg 57 during the simulation.
System Residues (atoms) pH5 pH6 pH7
Chain A Chain B Chain A Chain B Chain A Chain B
HIV-PRfree E35(OE1/OE2) – R57(NH1/NH2) 78 79 60 83 74 89
HIV-PRp1p6 E35(OE1/OE2) – R57(NH1/NH2) 88 90 75 66 68 75
HIV-PRnel E35(OE1/OE2) – R57(NH1/NH2) 72 90 90 79 78 42
R.O. Soares et al. / Data in Brief 8 (2016) 1144–1150 1149model (igb¼2) [15–17] under NVT ensemble. Before the simulation only the Asp25’ was protonated.
For non-bonded interactions was employed a cutoff 30 Å. The system temperature was maintained at
300 K using the Berendsen thermostat [18]. All bond lengths involving hydrogen atoms were con-
strained using the SHAKE algorithm [19]. The same processes described in the previous section were
also employed in this step, all Glu, Asp and His residues were allowed to change protonation states (18
residues). Protonation state change attempts were made every 10 fs.Acknowledgments
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